Skip to content

Chinese herb medicine iontophoresis for community-acquired pneumonia: A pilot study

The revision of community-acquired pneumonia clinical outcome assessment tool based on the combination of disease and syndrome and its application in the outcome assessment in clinical trial of traditional Chinese medicine

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300068040
Enrollment
Unknown
Registered
2023-02-03
Start date
2023-02-03
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

community-acquired pneumonia

Interventions

Experimental group:Chinese herb medicine iontophoresis plus standard treatment
Control group:Standard treatment

Sponsors

The First Affiliated Hospital of He'nan University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients who are diagnosed with community-acquired pneumonia; 2. Patients who are aged between 18 and 80 years; 3. Patients who are able to communicate and read in Chinese; 4. Patients who are willing to participate in the study and provide written informed consent.

Exclusion criteria

Exclusion criteria: 1. Women who are pregnant or lactating; 2. Patients with pleural effusion, bronchiectasis, active pulmonary tuberculosis or pulmonary abscess; 3. Patients who have neuromuscular diseases with risk of aspiration or are bedridden; 4. Patients who have a history of tumor, severe cardiovascular, cerebrovascular, liver or kidney diseases; 5. Patients who are participating in other interventional trials; 6. Patients who are allergic to the drug used.

Design outcomes

Primary

MeasureTime frame
Community-acquired pneumonia symptom questionnaire;

Secondary

MeasureTime frame
Community-acquired pneumonia patient-reported outcome scale;Community-acquired pneumonia clinician-reported outcome scale;Length of stay;Inflammation index;

Countries

China

Contacts

Public ContactJiajia Wang
wangiahn@163.com+86 371 6624 8624

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026